-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G9jMLojXgMp/WeJw+BW3yv69f1ERhH7IMdviEytcvODMaio4iSgFpElZNOVyexiJ LRA9a9/4XJDXZdZX0ChG7A== 0001010412-06-000078.txt : 20061211 0001010412-06-000078.hdr.sgml : 20061211 20060313171217 ACCESSION NUMBER: 0001010412-06-000078 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANGUINE CORP CENTRAL INDEX KEY: 0000926287 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954347608 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 101 EAST GREEN ST STREET 2: #11 CITY: PASADENA STATE: CA ZIP: 91105 BUSINESS PHONE: 8184050079 MAIL ADDRESS: STREET 1: 101 EAST GREEN ST STREET 2: STE 11 CITY: PASADENA STATE: CA ZIP: 91105 CORRESP 1 filename1.txt Leonard W. Burningham Lawyer Hermes Building * Suite 205 455 East 500 South Salt Lake City, Utah 84111-3323 Telephone (801) 363-7411 Fax (801) 355-7126 e-mail lwb@burninglaw.com March 13, 2006 U. S. Securities and Exchange Commission 450 Fifth Street, N.W. Stop 3561 Washington, D.C. 20549 Attention: Oscar M. Young, Jr. Re: Sanguine Corporation and SEC Comment Letter under date of January 18, 2006 Dear Mr. Young: Response 1(a) - Paragraph 9 of the Common Stock Purchase Warrant indicates that "Upon the occurrence of a Non-Registration Event" that the warrant holder would have the right to demand cash for the warrants, thus creating a "net- cash settlement" as defined under EITF 00-19. On April 25, 2002, the Company filed an S-3 Registration Statement registering the shares noted under the Common Stock Purchase Warrant agreement and updated this filing on May 7, 2002. This registration eliminated the event noted in paragraph 9 thus removing the "net-cash settlement" provision. Therefore, the Company recorded the value of the warrants as an equity transaction. All Annual Reports thereafter contained a Consent of Accountants respecting the Company's annual audited financial statements, so the S-3 Registration Statement is still effective and will remain so as long as the Company is current in its filings and includes such a Consent in its Annual Reports; all of these Common Stock Purchase Warrants expire in early 2007. Response 1(b) The Common Stock Purchase Warrant were not associated with any convertible debt but were associated with the warrant holders previous services. Thus the Company recorded the value of the warrants as compensation expense which is consistent with SFAS 123 paragraph 2. The Company valued the warrants using the Black-Scholes computations based upon prior trading values, a discount rate of 3.89% and a volatility of 107% and recognized the offsetting expense. Response 1(c) The warrants were not issued in connection with debt. Sincerely yours, /s/Leonard W. Burningham Leonard W. Burningham LWB/sg -----END PRIVACY-ENHANCED MESSAGE-----